William K. McVicar - 06 Jun 2022 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/ David J. Arthur, Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
06 Jun 2022
Net transactions value
+$5,000
Form type
4
Filing time
07 Jun 2022, 16:33:19 UTC
Previous filing
21 Jan 2022
Next filing
05 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $5,000 +26,553 $0.1883 26,553 06 Jun 2022 McVicar Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.